Bell Investment Advisors’s BioNTech BNTX Stock Holding History

Bell Investment Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.12K	Buy	12 +1	+9%	+$94	﹤0.01%	1505
2026 Q1	$978	Sell	11 -19	-63%	-$1.95K	﹤0.01%	1557
2025 Q4	$2.86K	Sell	30 -8	-21%	-$806	﹤0.01%	1216
2025 Q3	$3.75K	Hold	38	–	–	﹤0.01%	1060
2025 Q2	$4.05K	Sell	38 -11	-22%	-$1.11K	﹤0.01%	1080
2025 Q1	$4.46K	Hold	49	–	–	﹤0.01%	971
2024 Q4	$5.58K	Sell	49 -31	-39%	-$3.54K	﹤0.01%	880
2024 Q3	$9.5K	Buy	80 +4	+5%	+$368	﹤0.01%	644
2024 Q2	$6.11K	Buy	76 +35	+85%	+$3.2K	﹤0.01%	832
2024 Q1	$3.78K	Sell	41 -16	-28%	-$1.53K	﹤0.01%	1061
2023 Q4	$6.02K	Buy	57 +8	+16%	+$806	﹤0.01%	776
2023 Q3	$5.32K	Hold	49	–	–	﹤0.01%	777
2023 Q2	$5.29K	Buy	49 +33	+206%	+$3.71K	﹤0.01%	794
2023 Q1	$1.99K	Hold	16	–	–	﹤0.01%	1264
2022 Q4	$2.4K	Sell	16 -1	-6%	-$154	﹤0.01%	1191
2022 Q3	$2K	Buy	17 +4	+31%	+$612	﹤0.01%	1049
2022 Q2	$2K	Buy	+13	New	+$1.99K	﹤0.01%	1101
2021 Q4	$4K	Sell	14 -18	-56%	-$4.93K	﹤0.01%	836
2021 Q3	$9K	Buy	+32	New	+$10.2K	﹤0.01%	472

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Bell Investment Advisors's BNTX Position: Q2 2026 in Review

Bell Investment Advisors increased its BioNTech (BNTX) stake by 9.1% in Q2 2026, buying an estimated $94 and bringing the position to 12 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1505.

Bell Investment Advisors first reported a position in BNTX in Q3 2021 and has held it in 19 quarters since. The position peaked at $9.5K in Q3 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Bell Investment Advisors held 12 shares of BioNTech worth $1.12K as of Q2 2026.
Bell Investment Advisors bought 1 BioNTech share in Q2 2026, an estimated $94.
BioNTech made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1505 holding.
Bell Investment Advisors first reported a position in BioNTech in Q3 2021 and has held it in 19 quarters since.
Bell Investment Advisors's BioNTech position peaked at $9.5K in Q3 2024.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.